Back
HFA Premium Access

Efficacy and safety of dapagliflozin in the background of polypharmacy among patients with HFmrEF and HFpEF in the DELIVER trial

Session: Chronic heart failure - pharmacotherapy 4
Topic: Pharmacotherapy
Speaker: Doctor A. Peikert (Graz, AT)
Event: Heart Failure 2023

Congress Presentation

Add to my library

Like

About the speaker

Doctor Alexander Peikert

Medical University of Graz, Graz (Austria)
0 follower

7 more presentations in this session

Temporal trend in diuretic use in patients with heart failure with reduced ejection fraction on sacubitril/valsartan

Speaker: Doctor D. Jain (Dublin, IE)

Access
Abstract
Slides
Like
Thumbnail

Loop diuretic down titration at discharge in patients hospitalized for acute heart failure

Speaker: Doctor F. Croset (Madrid, ES)

Access
Abstract
Slides
Like
Thumbnail

Real-world analysis of heart failure medication before and after hospitalization for heart failure. Data from two large cohorts in the US and Germany.

Speaker: Doctor A. Michel (Basel, CH)

Access
Abstract
Slides
Like
Thumbnail

Changes in NT-proBNP following patiromer-facilitated optimisation of RAASi in patients with HFrEF with current or recent hyperkalaemia: a post hoc analysis of the DIAMOND study

Speaker: Professor L. Lund (Stockholm, SE)

Access
Abstract
Slides
Like
Thumbnail

Benefit of furher medical uptitration in heart failure with improved ejection fraction

Speaker: Doctor P. Puwatnuttasit (Bangkok, TH)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Chronic heart failure - pharmacotherapy 4

Speakers: Doctor A. Peikert, Doctor D. Jain, Doctor F. Croset, Doctor A. Michel, Professor L. Lund...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources